Emerging Markets Earnings Roundup: Sanofi And GSK (Part 6)
This article was originally published in PharmAsia News
Executive Summary
Emerging markets represent the biggest portion of Sanofi’s business, while GSK’s 10% growth in emerging markets for 2012 barely covered dismal European sales.